The TAPUR trial family: a global data sharing platform
9 Jul 2018
The TAPUR trial family: a global data sharing platform
Biobanking and early diagnosis to defeat NSCLC
Patients access to precision oncology
Early development in oncology: Are the MTD and monotherapy efficacy still the best objectives?
U.S. National Cancer Institute perspective on precision oncology
WINTHER & SPRING: Targeted agents and triple agent combinations
Precision medicine in newly diagnosed breast cancer
Implementing precision medicine in oncology: The IMPACT trials
Lessons from long-term survey of stage I NSCLC
Editor's Choice for June 2018
Improved OS with obinutuzumab in the CLL11 study
Editor’s Choice for May 2018